|
CH658973A5
(fr)
*
|
1983-12-29 |
1986-12-31 |
Nestle Sa |
Produit aromatisant.
|
|
JPS6197229A
(ja)
*
|
1984-10-18 |
1986-05-15 |
Chugai Pharmaceut Co Ltd |
安定なエリトロポエチン製剤
|
|
JPS63146828A
(ja)
*
|
1986-07-18 |
1988-06-18 |
Chugai Pharmaceut Co Ltd |
安定な顆粒球コロニ−刺激因子含有製剤
|
|
DE3729863A1
(de)
*
|
1987-09-05 |
1989-03-16 |
Boehringer Mannheim Gmbh |
Stabilisierte erythropoietin-lyophilisate
|
|
JPS649938A
(en)
|
1987-06-30 |
1989-01-13 |
Agency Ind Science Techn |
Oral ingestive composition
|
|
CA2028848A1
(en)
|
1989-04-11 |
1990-10-12 |
Tapan Audhya |
Lyophilized peptide formulations
|
|
IT1240314B
(it)
|
1989-09-28 |
1993-12-07 |
Immunobiology Research Institutes, Inc. |
Formulazioni acquose stabilizzate di piccoli peptidi.
|
|
US5221495A
(en)
*
|
1990-04-13 |
1993-06-22 |
Colgate-Palmolive Company |
Enzyme stabilizing composition and stabilized enzyme containing built detergent compositions
|
|
US5451410A
(en)
|
1993-04-22 |
1995-09-19 |
Emisphere Technologies, Inc. |
Modified amino acids for encapsulating active agents
|
|
US6284727B1
(en)
|
1993-04-07 |
2001-09-04 |
Scios, Inc. |
Prolonged delivery of peptides
|
|
US5681811A
(en)
|
1993-05-10 |
1997-10-28 |
Protein Delivery, Inc. |
Conjugation-stabilized therapeutic agent compositions, delivery and diagnostic formulations comprising same, and method of making and using the same
|
|
US5654278A
(en)
*
|
1994-10-13 |
1997-08-05 |
Novo Nordisk A/S |
Composition and method comprising growth hormone and leucine
|
|
US5593696A
(en)
|
1994-11-21 |
1997-01-14 |
Mcneil-Ppc, Inc. |
Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
|
|
US5904935A
(en)
|
1995-06-07 |
1999-05-18 |
Alza Corporation |
Peptide/protein suspending formulations
|
|
ZA965368B
(en)
*
|
1995-07-14 |
1997-01-14 |
Novo Nordisk As |
A pharmaceutical formulation
|
|
US5916582A
(en)
|
1996-07-03 |
1999-06-29 |
Alza Corporation |
Aqueous formulations of peptides
|
|
BR9710130A
(pt)
|
1996-07-03 |
1999-08-10 |
Alza Corp |
Formulações de peptídeos próticas não-aquosas
|
|
US5932547A
(en)
|
1996-07-03 |
1999-08-03 |
Alza Corporation |
Non-aqueous polar aprotic peptide formulations
|
|
US6541606B2
(en)
|
1997-12-31 |
2003-04-01 |
Altus Biologics Inc. |
Stabilized protein crystals formulations containing them and methods of making them
|
|
US6087478A
(en)
|
1998-01-23 |
2000-07-11 |
The Rockefeller University |
Crystal of the N-terminal domain of a STAT protein and methods of use thereof
|
|
WO2000004880A1
(en)
|
1998-07-23 |
2000-02-03 |
Novo Nordisk A/S |
A wet granulation method for preparing a stable pharmaceutical formulation
|
|
CA2352389C
(en)
|
1998-11-27 |
2009-01-20 |
Kanji Takada |
An oral formulation for gastrointestinal drug delivery
|
|
US6734162B2
(en)
|
2000-01-24 |
2004-05-11 |
Minimed Inc. |
Mixed buffer system for stabilizing polypeptide formulations
|
|
CA2413702A1
(en)
*
|
2000-06-28 |
2002-01-03 |
Teva Pharmaceuticals Industries Ltd. |
Carvedilol
|
|
FR2811884B1
(fr)
|
2000-07-21 |
2003-01-31 |
Oreal |
Utilisation en cosmetique de betainates d'amidon et composition les comprenant associes a au moins un agent benefique pour les matieres keratiniques
|
|
US6613308B2
(en)
|
2000-09-19 |
2003-09-02 |
Advanced Inhalation Research, Inc. |
Pulmonary delivery in treating disorders of the central nervous system
|
|
AU2001296389A1
(en)
|
2000-09-29 |
2002-04-08 |
Cognetix, Inc. |
Stable peptide formulations
|
|
WO2002055101A2
(en)
|
2000-12-21 |
2002-07-18 |
Inhale Therapeutic Syst |
Storage stable powder compositions of interleukin-4 receptor
|
|
CA2435835A1
(en)
|
2001-02-02 |
2002-08-15 |
Pharmacia Corporation |
Uroguanylin and cyclooxygenase-2 inhibitor combinations for inhibition of intestinal cancer
|
|
GB0104371D0
(en)
*
|
2001-02-22 |
2001-04-11 |
Clariant Int Ltd |
Color improving stabilizing compositions comprising leucine
|
|
US6573237B2
(en)
|
2001-03-16 |
2003-06-03 |
Eli Lilly And Company |
Protein formulations
|
|
WO2002078683A1
(en)
|
2001-03-29 |
2002-10-10 |
Synergy Pharmaceuticals, Inc. |
Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis
|
|
WO2003014304A2
(en)
|
2001-08-09 |
2003-02-20 |
Doctor's Signature Sales And Marketing International Corp. [(Dba)] Life Force International |
Protonic formulation
|
|
US20030104996A1
(en)
*
|
2001-08-30 |
2003-06-05 |
Tiansheng Li |
L-methionine as a stabilizer for NESP/EPO in HSA-free formulations
|
|
US20040161776A1
(en)
|
2001-10-23 |
2004-08-19 |
Maddon Paul J. |
PSMA formulations and uses thereof
|
|
PL370656A1
(en)
*
|
2001-12-21 |
2005-05-30 |
Novo Nordisk A/S |
Liquid composition of modified factor vii polypeptides
|
|
JP2003201256A
(ja)
|
2001-12-28 |
2003-07-18 |
Hisamitsu Pharmaceut Co Inc |
大腸送達性経口医薬製剤、大腸癌治療用経口医薬製剤および大腸炎治療用経口医薬製剤
|
|
DE10261126A1
(de)
*
|
2002-08-13 |
2004-03-04 |
Aventis Behring Gmbh |
Lagerungsstabile, flüssige Fibrinogen-Formulierung
|
|
CN1726012A
(zh)
|
2002-12-11 |
2006-01-25 |
辉瑞产品公司 |
活性物质在高脂肪环境中的控制释放
|
|
BR122018074353B8
(pt)
|
2003-01-28 |
2023-05-02 |
Ironwood Pharmaceuticals Inc |
composição farmacêutica, polipeptídeo e métodos para a produção dos mesmos
|
|
US7371727B2
(en)
|
2003-01-28 |
2008-05-13 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US7772188B2
(en)
|
2003-01-28 |
2010-08-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
US7304036B2
(en)
|
2003-01-28 |
2007-12-04 |
Microbia, Inc. |
Methods and compositions for the treatment of gastrointestinal disorders
|
|
DK1638586T3
(da)
*
|
2003-05-14 |
2008-06-23 |
Indus Biotech Pvt Ltd |
Synergistisk sammensætning til behandling af diabetes mellitus
|
|
CN1802171B
(zh)
*
|
2003-06-10 |
2010-10-13 |
株式会社Lg生命科学 |
不包含血清白蛋白的人红细胞生成素的稳定水溶液
|
|
US7494979B2
(en)
|
2003-06-13 |
2009-02-24 |
Ironwood Pharmaceuticals, Inc. |
Method for treating congestive heart failure and other disorders
|
|
PL1644021T3
(pl)
|
2003-06-13 |
2013-01-31 |
Ironwood Pharmaceuticals Inc |
Sposoby i kompozycje do leczenia zaburzeń żołądkowo-jelitowych
|
|
KR100560697B1
(ko)
|
2003-08-06 |
2006-03-16 |
씨제이 주식회사 |
알부민을 함유하지 않는 에리스로포이에틴 제제
|
|
DE102004011663B4
(de)
|
2004-03-10 |
2006-04-27 |
Bioceuticals Arzneimittel Ag |
Erythropoietin-Flüssigformulierung
|
|
WO2006071102A1
(en)
|
2004-12-30 |
2006-07-06 |
Dobeel Co., Ltd. |
Spray-dried composition containing collectin family proteins or variants therof and process for preparing the same
|
|
EP1940441A4
(en)
|
2005-08-19 |
2010-01-27 |
Ironwood Pharmaceuticals Inc |
COMPOSITIONS AND METHODS FOR TREATING GASTROINTESTINAL DISORDERS
|
|
WO2007044375A2
(en)
|
2005-10-06 |
2007-04-19 |
Nastech Pharmaceutical Company Inc. |
Pth formulations and methods of use
|
|
WO2007095716A1
(en)
|
2006-02-23 |
2007-08-30 |
Iomedix Sleep International Srl |
Compositions and methods for the induction and maintenance of quality sleep
|
|
US20090305993A1
(en)
|
2006-02-24 |
2009-12-10 |
Ironwood Pharmaceuticals, Inc. |
Methods and composition for the treatment of gastrointestinal disorders
|
|
ITMI20060629A1
(it)
*
|
2006-03-31 |
2007-10-01 |
Daniele Giovannone |
Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
|
|
EP2078529B1
(en)
|
2006-07-10 |
2014-12-10 |
PBA3 Biomed GmbH |
Antimicrobial peptides
|
|
PL2359808T3
(pl)
|
2006-08-09 |
2013-10-31 |
Intarcia Therapeutics Inc |
Osmotyczne systemy dostawcze i zespoły tłokowe
|
|
EP2059260B1
(en)
|
2006-08-31 |
2013-06-19 |
Novartis AG |
Pharmaceutical compositions comprising hGH for oral delivery
|
|
WO2008078189A2
(en)
*
|
2006-12-20 |
2008-07-03 |
Bayer Healthcare Llc |
Factor vii and viia compositions
|
|
EP2650303A1
(en)
|
2007-02-26 |
2013-10-16 |
Ironwood Pharmaceuticals, Inc. |
Methods and compositions for the treatment of heart failure and other disorders
|
|
GB0710321D0
(en)
*
|
2007-05-30 |
2007-07-11 |
Nhs Blood & Transplant |
Method
|
|
WO2008151257A2
(en)
|
2007-06-04 |
2008-12-11 |
Synergy Pharmaceuticals Inc. |
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
|
|
RS60101B1
(sr)
|
2008-08-15 |
2020-05-29 |
Ironwood Pharmaceuticals Inc |
Formulacije koje sadrže linaklotid za oralnu primenu
|
|
WO2010027405A2
(en)
|
2008-09-04 |
2010-03-11 |
Ironwood Pharmaceuticals, Inc. |
Stable solid formulations of gc-c receptor agonist polypeptides suitable for oral administration
|
|
US20120009225A1
(en)
|
2008-09-04 |
2012-01-12 |
Ironwood Pharmaceuticals, Inc. |
Stable Solid Formulation of Therapeutic Polypeptides Suitable for Oral Administration
|
|
JP5964589B2
(ja)
|
2008-12-03 |
2016-08-03 |
シナジー ファーマシューティカルズ インコーポレイテッド |
グアニル酸シクラーゼｃアゴニストの製剤およびその使用方法
|
|
WO2011019819A1
(en)
*
|
2009-08-12 |
2011-02-17 |
Forest Laboratories Holdings Limited |
Orally disintegrating compositions of linaclotide
|
|
US8748573B2
(en)
|
2009-08-06 |
2014-06-10 |
Ironwood Pharmaceuticals, Inc. |
Formulations comprising linaclotide
|